Royal London Asset Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-14,950
| Closed | -$3.68M | – | 683 |
|
|
2022
Q3 | $3.68M | Sell |
14,950
-1,110
| -7% | -$273K | 0.02% | 509 |
|
|
2022
Q2 | $3.98M | Hold |
16,060
| – | – | 0.02% | 512 |
|
|
2022
Q1 | $5.32M | Buy |
16,060
+304
| +2% | +$101K | 0.02% | 482 |
|
|
2021
Q4 | $5.66M | Sell |
15,756
-575
| -4% | -$207K | 0.02% | 466 |
|
|
2021
Q3 | $5.32M | Buy |
16,331
+432
| +3% | +$141K | 0.02% | 479 |
|
|
2021
Q2 | $4.96M | Hold |
15,899
| – | – | 0.02% | 516 |
|
|
2021
Q1 | $5.07M | Buy |
15,899
+487
| +3% | +$155K | 0.02% | 490 |
|
|
2020
Q4 | $5M | Sell |
15,412
-806
| -5% | -$261K | 0.03% | 450 |
|
|
2020
Q3 | $4.42M | Sell |
16,218
-32
| -0.2% | -$8.71K | 0.03% | 430 |
|
|
2020
Q2 | $3.9M | Sell |
16,250
-696
| -4% | -$167K | 0.03% | 439 |
|
|
2020
Q1 | $2.52M | Hold |
16,946
| – | – | 0.02% | 499 |
|
|
2019
Q4 | $2.83M | Hold |
16,946
| – | – | 0.02% | 540 |
|
|
2019
Q3 | $3.02M | Buy |
+16,946
| New | +$3.02M | 0.02% | 528 |
|
|
2019
Q2 | – | Sell |
-17,468
| Closed | -$4.99M | – | 648 |
|
|
2019
Q1 | $4.99M | Hold |
17,468
| – | – | 0.04% | 434 |
|
|
2018
Q4 | $5.56M | Buy |
17,468
+1,346
| +8% | +$428K | 0.05% | 368 |
|
|
2018
Q3 | $7.25M | Buy |
+16,122
| New | +$7.25M | 0.07% | 264 |
|